"Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.
The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

End User License Agreement (for non-institutional, personal use)

2. LINKING THE EGFR WITH CANCER THERAPUTICS

4. BIOMARKERS PREDICTING SENSITIVITY AND RESISTANCE TO ANTI-EGFR THERAPIES - LIGANDS OF THE EGFR AS PREDICTORS OF RESPONSE TO ANTI-EGFR THERAPY

5. BIOMARKERS PREDICTING SENSITIVITY AND RESISTANCE TO ANTI-EGFR THERAPIES - ALTERATIONS IN ERBB RECEPTORS FAMILY MEMBERS

6. Alterations in Non-ErbB Receptor Family Members

Tumor Resistance Mechanisms to Inhibitors Targeting the Epidermal Growth Factor Receptor– Part I: Extracellular Molecules

2. INTRACELLULAR TRAFFICKING OF THE egfr AND RESISTANCE TO ANTI-eGFR Therapy

3. The ras/ref/mek/erk Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

4. The PI3-K Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

5. ANALYSIS OF SEVERAL BIOMARKERS IN COMBINATION AND RESISTANCE TO ANTI-eGFR Therapy

6. The JAK/STAT Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

Tumor Resistance Mechanisms to Inhibitors Targeting the Epidermal Growth Factor Receptor – Part II: Intracellular Molecules

Chemotherapeutic, Immunologic, and Molecularly Targeted Therapy for the Treatment of Advanced Melanoma

1. THERAPEUTICAL APPROACHES TO CANCER: FROM Chemotherapy to Targeted Therapies

3. THE WARBURG EFFECT: CURRENT PERSPECTIVE

4. CURRENT AND PAST EFFORTS AT TARGETING THE WARBURG EFFECT FOR CANCER THERAPY

Targeting the Warburg Effect for Cancer Therapy: A Long and Winding Road

3. Previous Considerations before Therapy

6. Novel and Emerging Pharmacological Agents

7. Innovative Immunotherapy Strategies for Treatment of FL

Immunotherapy Strategies in Follicular Lymphoma: Antibodies, Vaccines and Cells

Cancer Epigenetics AND Role in Carcinogenesis

Modulation of Metabolism by Epigenetic Dys-regulation

Epigenetic Regulation by the Availability of Co-substrates

Epigenetic Dysregulation Induced by Oncometabolites

Epigenetics and Cancer Cell Metabolism: Cross-talk and Therapeutic Opportunities

Apoptosis Targeting Therapeutics in Clinical Trials

Bentham Science Publishers

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
 
 
The seventh volume of this series features reviews that cover the following topics related to the treatment of neurodegenerative diseases, epilepsy and stroke:
 
-Fatty Acid Amides as a New Potential Therapeutic Agent in Multiple Sclerosis
 
-Epileptic Seizures Detection Based on Non-Linear Characteristics Coupled with Machine Learning Techniques
 
-Hampering Essential Tremor Neurodegeneration in Essential Tremor: Present and Future Directions
 
-The Potential Therapeutic Role of the Melatoninergic System in Treatment of Epilepsy and Comorbid Depression
 
-Modeling Neurodegenerative Diseases Using Transgenic Model of Drosophila
 
-Genetic Basis in Stroke Treatment: Targets of Potent Inhibitors"


Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 7

Atta-ur-Rahman

 Zareen Amtul

"Recent Advances in Analytical Techniques is a collection of updates in techniques used in chemical analysis. This volume presents information about a selection of analytical techniques. Readers will find information about:
New methods of sample preparation in biological and environmental analysis
Developments in electrochemical sensors
In vivo cytometry for detection of tumor cells
Flow discharge spectroscopy for depth profile analysis
Advances in photodynamic therapy
New methods to analyze volatility in alcoholic beverages"


Recent Advances in Analytical Techniques: Volume 1

Sibel A. Ozkan

"Recent Advances in Analytical Techniques is a series of updates in techniques used in chemical analysis. Each volume presents information about a selection of analytical techniques. Readers will find information about developments in analytical methods such as chromatography, electrochemistry, optical sensor arrays for pharmaceutical and biomedical analysis. Novel Developments in Pharmaceutical and Biomedical Analysis is the second volume of the series and covers the following topics:
Chromatographic assays of solid dosage forms and their drug dissolution studies
UHPLC method for the estimation of bioactive compounds  
HILIC based LC/MS for metabolite analysis
In vitro methods for the evaluation of oxidative stress
Application of vibrational spectroscopy in studies of structural polymorphism of drugs
Electrochemical sensors based on conductive polymers and carbon nanotubes
Optical sensor arrays for pharmaceutical and biomedical analyses
Chemical applications of ionic liquids
New trends in enantioanalysis of pharmaceutical compounds
 "


Novel Developments in Pharmaceutical and Biomedical Analysis

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
The fifth volume of this series features reviews that cover the following topics:
-drug treatment for spinal cord injury
-action tremors
-natural products for Alzheimer’s disease treatment
-non pharmacological approaches towards pain management
-biosensors for detecting neurodegenerative diseases
-NMDA receptor targeting
-alkaloid antidepressants"


Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 5

"This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
 
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
 
 
 
The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively.
 
 
 
- Use of preclinical and early clinical data for accelerating antimicrobial drug development
 
- Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs
 
- Scope and limitations on the potent antimicrobial activities of hydrazone derivatives
 
- Current scenario of anti-leishmanial drugs and treatment
 
- Dengue hemorrhagic fever: the potential repurposing drugs"


Frontiers in Anti-Infective Drug Discovery: Volume 9

Dr. M. lqbal Choudhary 

"Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
 
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer’s Disease research.
 
The sixth volume of this series features chapters covering critical discussions on AD management and new therapies. The topics reviewed in this volume include:
- treatment of brain inflammation in Alzheimer’s disease with traditional medicine
- stem cell strategies for the modeling and therapy of Alzheimer’s disease
- retinal neurodegeneration in Alzheimer’s disease
- biological mass spectrometry for diagnosis of Alzheimer's disease
…and more."


Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 6

"Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD), a disease that causes dementia, or loss of brain function. This disease affects parts of the brain that affect memory, thought, and language. Chapters in each volume focus on drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
 
 
 
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research.
 
 
 
The eighth volume of this series features chapters covering critical discussions on new therapies for AD. The reviews in this volume include:
 
- Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications
 
- The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs
 
- Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease?
 
- Use of Antipsychotics in Patients with Alzheimer’s Disease
 
- Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease
 
- Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late-Onset Alzheimer's Disease"



Frontiers in Clinical Drug Research - Alzheimer Disorders Volume 8

"Advances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA. 
The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development. 
The contents of this volume include reviews on mediating or inhibiting different signaling pathways such as WNT signaling and MTOR as well as novel drug targets for tumor control such as neutrophil elastase and estrogen sulfatase. These reviews provide updates on new ways to treat a variety of cancers.
The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists."


Advances in Cancer Drug Targets: Volume 3

"Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. It presents comprehensive articles written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations. Contributions are written by eminent scientists and each volume is edited by an authority in the field. Advances in Organic Synthesis is essential for all organic chemists in the academia and industry who wish to keep abreast of rapid and important developments in the field.
 
This volume presents reviews on the following topics:
Small molecules that influence protein folding
Recent advances in peptide and protein synthesis
Bioorthogonal coupling for imaging and radiotherapy
Xanthenedione synthesis
Heterogeneous catalysis in organic synthesis"


Advances in Organic Synthesis: Volume 7

Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The fifth volume of this series brings 5 reviews which cover the following topics: - Resistin: an irresistible therapeutic target for inflammatory diseases, allergy-related disorders, and cancer- Asthma in adults: evaluation, prevalence, and its clinical management- Nitrogen-containing heterocycles as anti-allergy agents- Experimental and clinical studies on the effects of nigella sativa and its constituents on allergic and immunological disorders- Aspirin desensitization/challenge in patients with cardiovascular diseases: current trends and advances Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field

Votre panier

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

$ 99.00

description_of_book

Informations supplémentaires

À propos des auteurs

Atta-ur-Rahman

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 7

Recent Advances in Analytical Techniques: Volume 1

Novel Developments in Pharmaceutical and Biomedical Analysis

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 5

Frontiers in Anti-Infective Drug Discovery: Volume 9

Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 6

Frontiers in Clinical Drug Research - Alzheimer Disorders Volume 8

Advances in Cancer Drug Targets: Volume 3

Advances in Organic Synthesis: Volume 7

Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 5

Atta-ur-Rahman